Company / Financials
BioNexus Gene Lab Corp Financials
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$7.4M
FY2025 · -21.9% YoY
Net Income
-$3.0M
FY2025 · -86.7% YoY
Profit Margin
-40.2%
FY2025 · net income / revenue
ROE
-34.6%
FY2025 · return on equity
Total Assets
$9.3M
FY2025
Total Debt
-
FY2025
Equity
$8.6M
FY2025
ROA
-32.3%
FY2025 · return on assets
Statement paths
Metric history
Revenue HistoryTotal revenue from operations$7.4M-21.9% YoYNet Income HistoryProfit after all expenses and taxes-$3.0M-86.7% YoYGross Profit HistoryRevenue minus cost of goods sold$1.1M-15.8% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$6.3M-22.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$3.0M-88.4% YoYSG&A Expense HistorySelling, general, and administrative expenses$1.5M-16.2% YoYR&D Expense HistoryResearch and development spending$50.7K+6.6% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$0+100.0% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-